Cargando…
High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
Anaphylatoxin C5a, a potent pro-inflammatory peptide produced in the process of complement activation, was proved to have a vital role in tumor initiation and progession by previous investigations. However whether it could act as a prognostic marker remains unknown. Here we retrospectively enrolled...
Autores principales: | Xi, Wei, Liu, Li, Wang, Jiajun, Xia, Yu, Bai, Qi, Long, Qilai, Wang, Yiwei, Xu, Jiejie, Guo, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933887/ https://www.ncbi.nlm.nih.gov/pubmed/27381421 http://dx.doi.org/10.1038/srep29177 |
Ejemplares similares
-
Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
por: Wang, Jiajun, et al.
Publicado: (2017) -
Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2017) -
Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2015) -
Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xi, Wei, et al.
Publicado: (2016) -
Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)